Context Therapeutics Inc.

NAS: CNTX

GO
/marketstate/country/us

Market open

 --Quotes are delayed by 20 min

Aug 10, 2022, 1:07 p.m.

/zigman2/quotes/228313454/composite

$

1.85

Change

-0.0050 -0.27%

Volume

Volume 55,574

Quotes are delayed by 20 min

/zigman2/quotes/228313454/composite

Previous close

$ 1.85

$ 1.85

Change

-0.0050 -0.27%

Day low

Day high

$1.82

$1.90

Open

52 week low

52 week high

$1.27

$10.87

Open

Insider Actions for Context Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/16/2021 Martin A. Lehr
Chief Executive Officer; Director
13,000   Acquisition at $3.22 per share. 41,860
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
10,000   Acquisition at $5 per share. 50,000
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
10,000   Acquisition at $5 per share. 50,000
10/22/2021 Alex Levit
Chief Legal Officer, Corp. Sec
3,000   Acquisition at $5 per share. 15,000
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
586,475   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
210,715   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
586,476   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
210,722   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Evan G. Dick
SVP of R&D
26,587   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Evan G. Dick
SVP of R&D
26,587   Derivative/Non-derivative trans. at $0 per share. 0
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
52,680   376,135
10/22/2021 Martin A. Lehr
Chief Executive Officer; Director
52,680   376,135

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
0 Sales
0
0
Last 12 months
12 Purchases
0 Sales
1,788,922
0

Officers and Executives

Mr. Martin A. Lehr
President, Chief Executive Officer & Director
Ms. Jennifer Minai-Azary
Chief Financial Officer & Treasurer
Dr. Tarek Sahmoud
Chief Medical Officer
Dr. Evan G. Dick
Senior Vice President-Research & Development
Dr. Felix Kim
Advisor
Mr. Christopher Beck
Senior Vice President-Operations
Dr. Mark Fletcher
Vice President-Research & Development
Ms. Elizabeth Nemchik
Controller
Mr. Alex Levit
Secretary & Chief Legal Officer
Mr. Richard J. Berman
Chairman
Ms. Jennifer Evans Stacey
Independent Director
Dr. Philip Wayne Kantoff
Independent Director
Ms. Linda B. West
Independent Director
Link to MarketWatch's Slice.